These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34588353)

  • 1. [TREATMENT OF SEVERE ALLERGIC CONJUNCTIVITIS IN JAPAN, FOCUS ON IMMUNOSUPPRESSIVE EYE DROPS].
    Ebihara N
    Arerugi; 2021; 70(8):942-947. PubMed ID: 34588353
    [No Abstract]   [Full Text] [Related]  

  • 2. Executive summary: Japanese guidelines for allergic conjunctival diseases 2021.
    Miyazaki D; Fukushima A; Uchio E; Shoji J; Namba K; Ebihara N; Takamura E; Fukuda K; Matsuda A; Okamoto S; Fukagawa K; Fujishima H; Ohno S; Ohashi Y;
    Allergol Int; 2022 Oct; 71(4):459-471. PubMed ID: 36096976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of corticosteroid eye drops for allergic eye diseases in children].
    Csorba A; Soproni A; Maneschg O; Nagy ZZ; Szamosi A
    Orv Hetil; 2019 Mar; 160(9):329-337. PubMed ID: 30798620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [GUIDELINES FOR THE CLINICAL MANAGEMENT OF ALLERGIC CONJUNCTIVAL DISEASE THE POINT OF THE MANAGEMENT WITH USING CONVENTIONAL TOOL AND EYE DROPS].
    Takamura E
    Arerugi; 2018; 67(2):103-107. PubMed ID: 29553108
    [No Abstract]   [Full Text] [Related]  

  • 5. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vernal keratoconjunctivitis: Result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment.
    Vichyanond P; Tantimongkolsuk C; Dumrongkigchaiporn P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P
    J Allergy Clin Immunol; 2004 Feb; 113(2):355-8. PubMed ID: 14767456
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of eye allergies].
    Kari O; Saari KM
    Duodecim; 2012; 128(3):291-7. PubMed ID: 22428383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of allergic conjunctivitis].
    Hidasi V
    Orv Hetil; 2000 Aug; 141(34):1859-65. PubMed ID: 11006710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops.
    Ozcan AA; Ersoz TR; Dulger E
    Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine A 0.1% Cationic Emulsion in Vernal Keratoconjunctivitis.
    Ghiglioni DG; Bruschi G; Centonze S; Calcinai E; Cozzi L; Osnaghi S; Viola F; Marchisio PG
    J Pediatr Ophthalmol Strabismus; 2022; 59(4):279. PubMed ID: 35856429
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of Topical Cyclosporine 0.05% the Treatment of Vernal Keratoconjunctivitis.
    Subedi K; Sharma B; Shrestha S
    Nepal J Ophthalmol; 2020 Jan; 12(23):39-47. PubMed ID: 32799238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New strategy in the treatment of vernal keratoconjunctivitis by calcineurin inhibitor eye drops].
    Ebihara N
    Arerugi; 2010 Nov; 59(11):1525-31. PubMed ID: 21119297
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine ophthalmic emulsion (Verkazia) for vernal keratoconjunctivitis.
    Med Lett Drugs Ther; 2023 May; 65(1675):70-72. PubMed ID: 37155251
    [No Abstract]   [Full Text] [Related]  

  • 14. Retrospective review on the use of topical cyclosporin a 0.05% for paediatric allergic conjunctivitis in Hong Kong Chinese.
    Wu MM; Yau GS; Lee JW; Wong AL; Tam VT; Yuen CY
    ScientificWorldJournal; 2014; 2014():396987. PubMed ID: 25386595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis.
    Shoji J; Ohashi Y; Fukushima A; Miyazaki D; Uchio E; Takamura E; Fujishima H; Namba K; Kumagai N; Ebihara N; Okamoto S
    Curr Eye Res; 2019 Jul; 44(7):796-805. PubMed ID: 30947551
    [No Abstract]   [Full Text] [Related]  

  • 16. Vernal keratoconjunctivitis: An update.
    Ghiglioni DG; Zicari AM; Parisi GF; Marchese G; Indolfi C; Diaferio L; Brindisi G; Ciprandi G; Marseglia GL; Miraglia Del Giudice M
    Eur J Ophthalmol; 2021 Nov; 31(6):2828-2842. PubMed ID: 34058899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ocular cytology in vernal keratoconjunctivitis.
    Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG
    Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To evaluate the efficacy and safety of olopatadine 0.1% ophthalmic solution and bepotastine 1.5% ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital.
    Sruthi V; Reddy RN; Sowmini K; Grace NS
    Indian J Pharmacol; 2020; 52(6):476-481. PubMed ID: 33666188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis.
    Daniell M; Constantinou M; Vu HT; Taylor HR
    Br J Ophthalmol; 2006 Apr; 90(4):461-4. PubMed ID: 16547328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical cyclosporin A in the management of vernal keratoconjunctivitis.
    Gupta V; Sahu PK
    Eye (Lond); 2001 Feb; 15(Pt 1):39-41. PubMed ID: 11318292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.